Your browser doesn't support javascript.
loading
Coronavirus disease 2019, hypertension, and renin-angiotensin-aldosterone system inhibitors.
Rizk, John G; Sanchis-Gomar, Fabian; Henry, Brandon M; Lippi, Giuseppe; Lavie, Carl J.
Afiliação
  • Rizk JG; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.
  • Sanchis-Gomar F; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.
  • Henry BM; The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
  • Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, Louisiana, USA.
Curr Opin Cardiol ; 37(5): 419-423, 2022 09 01.
Article em En | MEDLINE | ID: mdl-35913369

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hipertensão Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hipertensão Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article